Digital Liver Cancer Summit 2021: A global survey assessing the impact of COVID-19 on liver cancer has revealed delays in the screening, diagnosis, and treatment of the disease, with experts issuing stark warnings on liver cancer survival rates. February 5, 2021 The delays of screening programme…
4 February 2021 The month of February brings together several key actions to tackle cancer globally, and EASL is focussing particularly on the global threat of liver cancer. EASL draws on all these initiatives, in alignment with its goals embedded in our policy and public health strategies. [vc_s…
Digital Liver Cancer Summit 2021: As the latest data suggests, liver cancer is now the third-most deadly cancer in the world, claiming nearly 1 million lives in 2020, the liver community takes robust action to tackle the burden posed by the disease. February 4, 2021 Liver cancer has become an in…
In memoriam: Prof. Wolfgang Gerok (1926–2021) and Prof. Roberto Groszmann (1939–2021) 20 January 2021 EASL is greatly saddened to hear of the passing earlier this week of two giants of hepatology, Prof. Wolfgang Gerok (1926–2021) and Prof. Roberto Groszmann (1939–2021). They both devoted decades …
About EASL and the ALIVER Consortium The ALIVER Consortium of 11 institutions from seven European countries developed an innovative liver dialysis machine called Dialive™. This device helps the liver to regenerate naturally or, when that does not prove possible, keeps patients alive and healthy u…
This year has been unlike any other. COVID-19 brought unimaginable challenges to the medical community, placing you at the forefront of the pandemic. The year 2020 posed unique questions to those of us treating liver patients and focusing on liver diseases. A giant in hepatology, Prof. Roger Wil…
Researchers from EF Clif identify the causes that precipitate the onset of the most serious stage of cirrhosis: the syndrome of Acute-On-Chronic Liver Failure (ACLF). Barcelona, December 9, 2020 – A new investigation of the PREDICT study, which was led and coordinated from Barcelona by Prof. Jone…
16 November 2020 Awareness Week on Alcohol-Related Harm (AWARH) takes place yearly. It serves to raise awareness among EU policymakers of the types of harm caused by alcohol, to increase awareness about the need to address alcohol-related harm in Europe, and…
As a fully digital three-day event, Digital ILC 2020 brought together thousands of delegates from all over the world. EASL invited you, the delegates, to take part in the first ever EASL Share competition. We asked you to submit creative entries, anything from an image, drawing, or a piece of you…
On 4 November 2020, EASL held its first online Patient Forum, a vibrant exchange exploring synergies between our association of professionals and regional patient organisations engaged in the fight against liver disease. Scientists, practitioners, and patient advocates discussed two EASL Policy S…
